Coronavirus: What makes Oxford-AstraZeneca’s vaccine different from others approved
CA, 31 Dec 2020
On Wednesday, the U.K. became the first country to approve the COVID-19 vaccine from Oxford University and the drug maker AstraZeneca.
The U.K. is reporting nearly 1,000 new deaths – the most since April – and more than 50,000 new infections.
Redmond Shannon explains what makes the AstraZeneca vaccine different from those already approved.
For more info, please go to https://globalnews.ca/news/7547371/coronavirus-vaccine-astrazeneca-canada-uk-approval/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#coronavirus #COVID19 #AstraZeneca #GlobalNews
The U.K. is reporting nearly 1,000 new deaths – the most since April – and more than 50,000 new infections.
Redmond Shannon explains what makes the AstraZeneca vaccine different from those already approved.
For more info, please go to https://globalnews.ca/news/7547371/coronavirus-vaccine-astrazeneca-canada-uk-approval/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#coronavirus #COVID19 #AstraZeneca #GlobalNews
